Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 26Carcinoma, Hepatocellular 22Small Cell Lung Carcinoma 17Lung Neoplasms 14Neoplasms 13Breast Neoplasms 9Colorectal Neoplasms 7Carcinoma, Renal Cell 7Squamous Cell Carcinoma of Head and Neck 6Urinary Bladder Neoplasms 5Triple Negative Breast Neoplasms 5Prostatic Neoplasms 5Neoplasm Metastasis 5Melanoma 5Carcinoma, Transitional Cell 5Uterine Cervical Neoplasms 4Stomach Neoplasms 4Sarcoma 4Glioblastoma 4Solid Tumors 3Sarcoma, Alveolar Soft Part 3Ovarian Neoplasms 3Liver Neoplasms 3Extensive Stage Lung Small Cell Carcinoma 3Endometrial Neoplasms 3Carcinoma 3Treatment-Refractory Solid Tumors 2Small Cell Lung Cancer Extensive Stage 2Pancreatic Neoplasms 2Osteosarcoma 2

Interventions

pembrolizumab 8cemiplimab 5Nivolumab 4Ipilimumab 4Blood Specimen Collection 3lifileucel 2avelumab 2aldesleukin 2Niacinamide 2Cyclophosphamide 2toripalimab 1tislelizumab 1oxycodone-acetaminophen 1lenvatinib 1fludarabine 1epacadostat 1encorafenib 1durvalumab 1dostarlimab 1brodalumab 1binimetinib 1atezolizumab 1Vitamin A 1Surgical Procedures, Operative 1Sunscreening Agents 1Standard of Care 1Specimen Handling 1Resistance Training 1Radiotherapy 1Niacin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Skin Neoplasms × atezolizumab × 90 days × Clear all
NCT04387084 2026-03-23

Short-term Fasting Prior to PD-1/PD-L1 Inhibitor Therapy for of Advanced or Metastatic Skin Malignancy

University of Southern California

Phase 1 Active not recruiting
10 enrolled
Dermatologic

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡